Galimedix Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Galimedix inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Galimedix Inc Today - Breaking & Trending Today

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease

Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer's Disease
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Alexander Gebauer , Hermann Russ , Peter Serra , Galimedix Inc , Galimedix Therapeutics Inc , Executive Chairman Alexander Gebauer , Galimedix Therapeutics , அலெக்சாண்டர் கேபோஊெர் , ஹெர்மன் ரஸ் ,

Investegate |Secarna Pharmaceuticals GmbH & Announcements | Secarna Pharmaceuticals GmbH &: Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director


DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG
/ Key word(s): Personnel
Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director
04.02.2021 / 14:00
Secarna Pharmaceuticals appoints Alexander Gebauer, MD, PhD as CEO and Managing Director
Munich/Martinsried, Germany, February 04, 2021 - Secarna Pharmaceuticals GmbH & Co. KG ( Secarna ), a biopharmaceutical company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplus
TM platform, announced today that the Company has appointed Alexander Gebauer, MD, PhD as CEO and Managing Director. Dr. Gebauer brings more than 25 years of experience in the pharmaceutical and biotechnology industry in leadership roles in North America, Europe and India. His focus has been on R&D, from early discovery up to launch and life cycle management, as well as business development a ....

United Kingdom , United States , Sun Pharma , Planegg Martinsried , Christian Pangratz , Alexander Gebauer , Secarna Pharmaceuticals Gmbh Co , Omeicos Ophthalmics Inc , Merz Pharmaceuticals , Hoechst Group Aventis Sanofi , Sun Pharma Group , Johannes Gutenberg University , Secarna Pharmaceuticals , Galimedix Inc , Head Global Research Development , Ranbaxy Laboratories Limited Sun Pharma , International Pharmacoeconomics , Pharmaceuticals Gmbh , North America , Managing Director , Omeicos Ophthalmics , Berlin Based Omeicos Therapeutics Gmbh , Ranbaxy Laboratories Limited , Senior Vice President , Head Global Research , Clinical Discovery ,